Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021687
Company: ORGANON
Company: ORGANON
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | AB | Yes | No |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | AB | Yes | No |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | AB | Yes | No |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/23/2004 | ORIG-1 | Approval | Type 4 - New Combination | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21687lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21687ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-687_Vytorin.cfm |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/28/2024 | SUPPL-66 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s066lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s066ltr.pdf | |
| 02/08/2024 | SUPPL-65 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s061, s064, s065ltr.pdf | |
| 02/08/2024 | SUPPL-64 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s061, s064, s065ltr.pdf | |
| 09/25/2020 | SUPPL-63 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021687s063lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s061, s064, s065ltr.pdf | |
| 10/04/2019 | SUPPL-62 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021687s062lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021687Orig1s062ltr.pdf | |
| 02/08/2024 | SUPPL-61 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s061, s064, s065ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021687Orig1s061, s064, s065ltr.pdf | |
| 02/28/2018 | SUPPL-60 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021687s060lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021687Orig1s060ltr.pdf | |
| 01/19/2017 | SUPPL-57 | Manufacturing (CMC) |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/021687Orig1s057.pdf |
| 02/02/2015 | SUPPL-53 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021687s053lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021687Orig1s053ltr.pdf | |
| 04/02/2019 | SUPPL-52 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021687s052lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021687Orig1s052ltr.pdf | |
| 09/30/2014 | SUPPL-51 | Labeling-Package Insert |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021687Orig1s051ltr.pdf |
| 02/27/2014 | SUPPL-50 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021687s050lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021687Orig1s050ltr.pdf | |
| 10/25/2013 | SUPPL-48 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021687s048lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021687Orig1s048ltr.pdf | |
| 10/31/2012 | SUPPL-47 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s046s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021687Orig1s046,s047ltr.pdf | |
| 10/31/2012 | SUPPL-46 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s046s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021687Orig1s046,s047ltr.pdf | |
| 02/28/2012 | SUPPL-44 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021687s044ltr.pdf | |
| 12/01/2011 | SUPPL-42 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021687s042ltr.pdf | |
| 10/06/2011 | SUPPL-41 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s041lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021687s041ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021687Orig1s041.pdf | |
| 06/08/2011 | SUPPL-40 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s033s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021687s033,s040ltr.pdf | |
| 01/24/2012 | SUPPL-39 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021687s039ltr.pdf | |
| 12/22/2010 | SUPPL-37 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021687s037ltr.pdf | |
| 04/22/2010 | SUPPL-36 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021687s036ltr.pdf | |
| 03/10/2010 | SUPPL-34 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021687s034ltr.pdf | |
| 06/08/2011 | SUPPL-33 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s033s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021687s033,s040ltr.pdf | |
| 11/06/2009 | SUPPL-32 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021687s032ltr.pdf | |
| 01/30/2009 | SUPPL-30 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021687s030ltr.pdf | |
| 01/08/2009 | SUPPL-29 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021687s029ltr.pdf | |
| 06/13/2008 | SUPPL-25 | Labeling |
Label is not available on this site. |
||
| 06/13/2008 | SUPPL-23 | Efficacy-New Patient Population |
Label is not available on this site. |
||
| 02/08/2008 | SUPPL-22 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021687s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021687s022ltr.pdf | |
| 12/12/2007 | SUPPL-21 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021687s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021687s021ltr.pdf | |
| 05/16/2007 | SUPPL-19 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021687s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021687s019ltr.pdf | |
| 11/27/2006 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s016ltr.pdf | |
| 07/03/2006 | SUPPL-15 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s015LTR.pdf | |
| 03/16/2006 | SUPPL-13 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s006,s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s006,s013ltr.pdf | |
| 10/03/2006 | SUPPL-11 | Efficacy-Accelerated Approval Confirmatory Study |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s011LTR.pdf | |
| 10/24/2006 | SUPPL-10 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s010ltr.pdf | |
| 12/09/2005 | SUPPL-9 | Manufacturing (CMC)-Control |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021687s009ltr.pdf | |
| 03/16/2006 | SUPPL-6 | Efficacy-Accelerated Approval Confirmatory Study |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s006,s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021687s006,s013ltr.pdf | |
| 10/19/2005 | SUPPL-4 | Labeling |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s004lbl.pdf | |
| 06/03/2005 | SUPPL-3 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021687s003ltr.pdf | |
| 03/07/2005 | SUPPL-2 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21687s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/21687s002ltr.pdf | |
| 02/16/2005 | SUPPL-1 | Manufacturing (CMC)-Packaging |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021687s001ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/28/2024 | SUPPL-66 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s066lbl.pdf | |
| 02/08/2024 | SUPPL-65 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf | |
| 02/08/2024 | SUPPL-65 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf | |
| 02/08/2024 | SUPPL-64 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf | |
| 02/08/2024 | SUPPL-61 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021687s061s064s065lbl.pdf | |
| 09/25/2020 | SUPPL-63 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021687s063lbl.pdf | |
| 10/04/2019 | SUPPL-62 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021687s062lbl.pdf | |
| 04/02/2019 | SUPPL-52 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021687s052lbl.pdf | |
| 02/28/2018 | SUPPL-60 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021687s060lbl.pdf | |
| 02/02/2015 | SUPPL-53 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021687s053lbl.pdf | |
| 02/27/2014 | SUPPL-50 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021687s050lbl.pdf | |
| 10/25/2013 | SUPPL-48 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021687s048lbl.pdf | |
| 10/31/2012 | SUPPL-47 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s046s047lbl.pdf | |
| 10/31/2012 | SUPPL-46 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s046s047lbl.pdf | |
| 02/28/2012 | SUPPL-44 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s044lbl.pdf | |
| 01/24/2012 | SUPPL-39 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021687s039lbl.pdf | |
| 12/01/2011 | SUPPL-42 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s042lbl.pdf | |
| 10/06/2011 | SUPPL-41 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s041lbl.pdf | |
| 06/08/2011 | SUPPL-40 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s033s040lbl.pdf | |
| 06/08/2011 | SUPPL-33 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021687s033s040lbl.pdf | |
| 12/22/2010 | SUPPL-37 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s037lbl.pdf | |
| 04/22/2010 | SUPPL-36 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s036lbl.pdf | |
| 03/10/2010 | SUPPL-34 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021687s034lbl.pdf | |
| 11/06/2009 | SUPPL-32 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s032lbl.pdf | |
| 01/30/2009 | SUPPL-30 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s030lbl.pdf | |
| 01/08/2009 | SUPPL-29 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021687s029lbl.pdf | |
| 02/08/2008 | SUPPL-22 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021687s022lbl.pdf | |
| 12/12/2007 | SUPPL-21 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021687s021lbl.pdf | |
| 05/16/2007 | SUPPL-19 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021687s019lbl.pdf | |
| 11/27/2006 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s016lbl.pdf | |
| 10/24/2006 | SUPPL-10 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s010lbl.pdf | |
| 10/03/2006 | SUPPL-11 | Efficacy-Accelerated Approval Confirmatory Study | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s011lbl.pdf | |
| 07/03/2006 | SUPPL-15 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s015lbl.pdf | |
| 03/16/2006 | SUPPL-13 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s006,s013lbl.pdf | |
| 03/16/2006 | SUPPL-6 | Efficacy-Accelerated Approval Confirmatory Study | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021687s006,s013lbl.pdf | |
| 12/09/2005 | SUPPL-9 | Manufacturing (CMC)-Control | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s009lbl.pdf |
| 10/19/2005 | SUPPL-4 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s004lbl.pdf | |
| 06/03/2005 | SUPPL-3 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021687s003lbl.pdf | |
| 03/07/2005 | SUPPL-2 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21687s002lbl.pdf | |
| 07/23/2004 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21687lbl.pdf |
VYTORIN
TABLET;ORAL; 10MG;10MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 209222 | ALKEM LABS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 208831 | AMNEAL PHARMS CO |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 200082 | AUROBINDO PHARMA USA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 200909 | DR REDDYS LABS SA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 208699 | GLENMARK PHARMS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | No | AB | 202968 | WATSON LABS INC |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET;ORAL | Prescription | Yes | AB | 021687 | ORGANON |
TABLET;ORAL; 10MG;20MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 209222 | ALKEM LABS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 208831 | AMNEAL PHARMS CO |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 200082 | AUROBINDO PHARMA USA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 200909 | DR REDDYS LABS SA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 208699 | GLENMARK PHARMS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | No | AB | 202968 | WATSON LABS INC |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET;ORAL | Prescription | Yes | AB | 021687 | ORGANON |
TABLET;ORAL; 10MG;40MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 209222 | ALKEM LABS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 208831 | AMNEAL PHARMS CO |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 200082 | AUROBINDO PHARMA USA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 200909 | DR REDDYS LABS SA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 208699 | GLENMARK PHARMS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | No | AB | 202968 | WATSON LABS INC |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET;ORAL | Prescription | Yes | AB | 021687 | ORGANON |
TABLET;ORAL; 10MG;80MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 209222 | ALKEM LABS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 208831 | AMNEAL PHARMS CO |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 200082 | AUROBINDO PHARMA USA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 200909 | DR REDDYS LABS SA |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 208699 | GLENMARK PHARMS LTD |
| EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | No | AB | 202968 | WATSON LABS INC |
| VYTORIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET;ORAL | Prescription | Yes | AB | 021687 | ORGANON |